← Leaderboards
Robert Anthony Orlando
University Of California San Diego
$1,178,302
Attributed
$1,178,302
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $148.5K · FY2007–08$200K$150K$100K$50K$0
'07
'08
Funding mix
By agency
NIH$1,178,302 · 2
By mechanism
R01$884,641 · 1
R21$293,661 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Diego
Same institution · by research overlap
- Jeffrey D Esko$29,504,748
- Ajit P Varki$39,470,453
- James B Brewer$11,942,997
- James A McCammon$10,414,067
- Elizabeth A. Komives$22,830,718
Others in their field
Top investigators on “Receptor Mediated Endocytosis”
- Mark E. Von Zastrow · University Of California, San Francisco$18,410,309
- Sandra L. Schmid · Scripps Research Institute$15,005,074
- Nigel W Bunnett · New York University$12,164,517
- Alexander D Sorkin · University Of Pittsburgh At Pittsburgh$11,075,103
- Tomas Kirchhausen · Boston Children'S Hospital$10,111,678
- Jeffrey L Benovic · Thomas Jefferson University$9,896,166
Research focus
Receptor Mediated EndocytosisHeparan SulfateLaboratory RabbitReceptor ExpressionLow Density Lipoprotein ReceptorBlood Lipoprotein MetabolismGenetic Regulatory ElementLaboratory MouseLipaseReceptor BindingTranscription FactorProteoglycanCell DifferentiationBlood Lipoprotein TransportAdipocytesGenetic Promoter ElementBiological AvailabilityBeta Pleated SheetAmino AcidsBaseClinical TrialsAnalogAlzheimer&AposAcetylcholine
Grant awards (6)
Curcumin-based analogs as improved inhibitors of Abeta aggregation$145,185
R21 · FY2008 · AG · contact PI
Curcumin-based analogs as improved inhibitors of Abeta aggregation$148,476
R21 · FY2007 · AG · contact PI
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM$294,000
R01 · FY2003 · HL
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM$294,000
R01 · FY2002 · HL
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM$274,101
R01 · FY2000 · HL
CELL SURFACE ACTIVITIES IN LIPOPROTEIN CATABOLISM$22,540
R01 · FY2000 · HL